- 01US Q1 revenue rose 152% YoY to US$381,612.
- 02OptiBlend +247%; EdenCrete Pz7 +279%.
- 03Six Pz7 installs; 32 sites installed/pending across US, Canada, Ecuador.
Eden Innovations (ASX: EDE) has reported a 152% year-on-year increase in total US revenue for the first quarter of the 2027 financial year to US$381,612 (A$549,521), driven by stronger OptiBlend and EdenCrete sales.
OptiBlend revenue rose 247% to US$259,863 (A$374,203), while EdenCrete Pz7 sales climbed 279% to US$75,770 (A$109,109).
Sales across all EdenCrete products increased 60% to US$121,749 (A$175,319), supported by starter volumes for newly installed plants and replenishment orders from existing customers.
Eden added six new EdenCrete Pz7 bulk storage and dispensing installations at ready-mix concrete plants during the quarter.
Two more are scheduled for October, taking the number of installed or pending sites across the US, Canada, and Ecuador to 32.
OptiBlend Sales Growth
OptiBlend sales during Q1 FY27 comprised nine orders for kits and installation services supplied to generator packagers, drilling contractors, and other customers in Texas, Louisiana, and Florida, along with Eden’s first export sale to Brazil.
The business generated 19 new OptiBlend quotes worth US$1,067,329 during the quarter, comprising 16 in the US, two in Mexico, and one in Bolivia.
Eden also submitted a quote worth about US$249,000 with a generator supplier bidding to the US Army Corp of Engineers, and planned two kit installations worth about US$110,000 during October.
Outside the US, Eden India is pursuing OptiBlend opportunities in India, the Middle East, and Africa as the group looks to extend the product’s market reach.
EdenCrete Pz7 Installations
The new Q1 FY27 EdenCrete Pz7 installations comprised three plants in Colorado, two in Texas, and one in Minnesota, while the rollout also included a further plant in the greater Toronto area of Canada.
Each new installation is accompanied by a starter order that Eden says typically generates US$6,000 to US$10,000 in sales before a plant optimises dosages and mix designs and moves towards regular daily consumption.
Based on sales history, Eden estimates each fully integrated plant could progressively build annual EdenCrete Pz7 purchases to about US$40,000 to US$80,000 over one to two years, depending on the concrete strength being supplied.
Eden has supplied EdenCrete Pz7 to nine Holcim plants in Ecuador since 2024, where cumulative purchases exceed US$697,830.
Holcim is reviewing dispensing-system rollouts in two further South American countries, and continuing extended trials in the United Kingdom and France.
Get the wire before the market opens.
The ASX small-cap stories that matter, filed before 9am AEST. Curated by the Small Caps desk.